Ziprasidone in treatment of resistant obsessive-compulsive disorder in a female adolescent
Joint Authors
Mani, A.
Vahdani, A.
Haghighat, R.
Source
Iranian Red Crescent Medical Journal
Issue
Vol. 11, Issue 4 (31 Oct. 2009), pp.461-463, 3 p.
Publisher
Publication Date
2009-10-31
Country of Publication
United Arab Emirates
No. of Pages
3
Main Subjects
Topics
Abstract EN
While serotonin reuptake inhibitors (SSRIs) and behavioral therapy are the first-line agents in treatment of obsessive-compulsive disorder (OCD), 40-60 % of patients with the disorder do not respond to therapy.
So other neurotransmitters may play a role in OCD.
In this regard, there has been particular interest in the dopaminergic system, with various antipsychotic drugs having been used as adjunctive therapy for refractory OCD.
This study describes the efficacy of ziprasidone as adjuncts for treatment-resistant OCD in a young female adolescent.
American Psychological Association (APA)
Vahdani, A.& Haghighat, R.& Mani, A.. 2009. Ziprasidone in treatment of resistant obsessive-compulsive disorder in a female adolescent. Iranian Red Crescent Medical Journal،Vol. 11, no. 4, pp.461-463.
https://search.emarefa.net/detail/BIM-62362
Modern Language Association (MLA)
Vahdani, A.…[et al.]. Ziprasidone in treatment of resistant obsessive-compulsive disorder in a female adolescent. Iranian Red Crescent Medical Journal Vol. 11, no. 4 (Oct. 2009), pp.461-463.
https://search.emarefa.net/detail/BIM-62362
American Medical Association (AMA)
Vahdani, A.& Haghighat, R.& Mani, A.. Ziprasidone in treatment of resistant obsessive-compulsive disorder in a female adolescent. Iranian Red Crescent Medical Journal. 2009. Vol. 11, no. 4, pp.461-463.
https://search.emarefa.net/detail/BIM-62362
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 463
Record ID
BIM-62362